In these models, the high level of tumor cell-specific beta-catenin signaling is accompanied by high-level production of Wnt inhibitors DKK1 and WIF1, which reprogram the intra-tumor vascular phenotype by inhibiting beta-catenin signaling in ECs. Here, CTNNB1 is linked to neoplasm.